Read More

GE Healthcare Has Completed Recruitment In Its Phase 1 Program For A Manganese-Based Macrocyclic MRI Contrast Agent. This Manganese-Based Agent Could Provide A Potential Alternative Due To Perceived Concerns Relating To Gadolinium Retention

GE HealthCare has today announced, at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clinical development program for a first-of-its-kind

GEHC